All News


All series


All All News

“If you locked everybody in a room for a week, I think we could come up with something that everybody would be comfortable with,” said Blase Polite, M.D., a co-author of the statement, and immediate past chair of ASCO’s government relations committee.

The doctor-patient relationship is a delicate one. It's one that needs to be comfortable between both parties. When and how do breast cancer patients know when it's time to make a change? This is an important decision that should not be taken lightly.

Summer fun can be a challenge for survivors with lymphedema. While you should do what your doctor, physical therapist and you have worked out as best for your needs, I share some of my helpful habits here.

Blincyto (blinatumomab) was granted full approval by the Food and Drug Administration (FDA) to treat both children and adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (ALL), regardless of Philadelphia chromosome (Ph) status, according to the developer of the anti-CD19 immunotherapy, Amgen.